NO20056171L - Kombinasjonsterapi - Google Patents

Kombinasjonsterapi

Info

Publication number: NO20056171L
Authority: NO; Norway
Prior art keywords: azd2171; human; antiangiogenic; warm; treated
Prior art date: 2003-07-10

Application number

NO20056171A

Other languages

English (en)

Norwegian (no)

Inventor

Stephen Robert Wedge

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-10

Filing date

2005-12-23

Publication date

2006-02-07

2005-12-23 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-02-07 Publication of NO20056171L publication Critical patent/NO20056171L/no

Links

238000002648 combination therapy Methods 0.000 title 1
XXJWYDDUDKYVKI-UHFFFAOYSA-N 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline Chemical compound COC1=CC2=C(OC=3C(=C4C=C(C)NC4=CC=3)F)N=CN=C2C=C1OCCCN1CCCC1 XXJWYDDUDKYVKI-UHFFFAOYSA-N 0.000 abstract 5
229960002412 cediranib Drugs 0.000 abstract 5
241001465754 Metazoa Species 0.000 abstract 3
206010028980 Neoplasm Diseases 0.000 abstract 3
238000004519 manufacturing process Methods 0.000 abstract 3
238000000034 method Methods 0.000 abstract 3
230000001772 anti-angiogenic effect Effects 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 2
230000005855 radiation Effects 0.000 abstract 2
230000001603 reducing effect Effects 0.000 abstract 2
230000008728 vascular permeability Effects 0.000 abstract 2
239000013066 combination product Substances 0.000 abstract 1
229940127555 combination product Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Iron Core Of Rotating Electric Machines (AREA)

NO20056171A 2003-07-10 2005-12-23 Kombinasjonsterapi NO20056171L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0316123.9A GB0316123D0 (en)	2003-07-10	2003-07-10	Combination therapy
PCT/GB2004/002937 WO2005004871A1 (en)	2003-07-10	2004-07-07	Combination therapy

Publications (1)

Publication Number	Publication Date
NO20056171L true NO20056171L (no)	2006-02-07

Family

ID=27741905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20056171A NO20056171L (no)	2003-07-10	2005-12-23	Kombinasjonsterapi

Country Status (17)

Country	Link
US (1)	US20060160775A1 (de)
EP (1)	EP1651227B1 (de)
JP (1)	JP2007526887A (de)
KR (1)	KR20060034287A (de)
CN (1)	CN100435799C (de)
AT (1)	ATE385798T1 (de)
AU (1)	AU2004255023B2 (de)
BR (1)	BRPI0412450A (de)
CA (1)	CA2531643A1 (de)
DE (1)	DE602004011781T2 (de)
ES (1)	ES2299841T3 (de)
GB (1)	GB0316123D0 (de)
IL (1)	IL172682A0 (de)
MX (1)	MXPA06000413A (de)
NO (1)	NO20056171L (de)
WO (1)	WO2005004871A1 (de)
ZA (1)	ZA200600188B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0008269D0 (en)	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
MXPA06010755A (es) *	2004-03-23	2006-12-15	Astrazeneca Ab	Terapia de combinacion.
GB0406445D0 (en) *	2004-03-23	2004-04-28	Astrazeneca Ab	Combination therapy
KR20080031029A (ko) *	2005-07-06	2008-04-07	아스트라제네카 아베	Ａｚｄ2171 및 젬시타빈에 의한 암의 병용 요법
HRP20110365T1 (hr) *	2005-12-22	2011-06-30	Astrazeneca Ab	Kombinacija azd2171 i pemetrekseda
TW200922590A (en) *	2007-09-10	2009-06-01	Curis Inc	VEGFR inhibitors containing a zinc binding moiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9714249D0 (en) *	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
AU762615B2 (en) *	1998-06-15	2003-07-03	Arch Development Corporation	Combination of radiotherapy and anti-angiogenic factors
PT1154774E (pt) *	1999-02-10	2005-10-31	Astrazeneca Ab	Derivados de quinazolina como inibidores de angiogenese
PL357282A1 (en) *	2000-03-31	2004-07-26	Angiogene Pharmaceuticals Ltd.	Divided dose therapies with vascular damaging activity
EE200200565A (et) *	2000-03-31	2004-06-15	Angiogene Pharmaceuticals Ltd.	Vaskulaarse kahjustava toimega kombinatsioonravi
GB0008269D0 (en) *	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy

2003
- 2003-07-10 GB GBGB0316123.9A patent/GB0316123D0/en not_active Ceased
2004
- 2004-07-07 AU AU2004255023A patent/AU2004255023B2/en not_active Ceased
- 2004-07-07 JP JP2006518354A patent/JP2007526887A/ja active Pending
- 2004-07-07 AT AT04743280T patent/ATE385798T1/de not_active IP Right Cessation
- 2004-07-07 BR BRPI0412450-2A patent/BRPI0412450A/pt not_active IP Right Cessation
- 2004-07-07 ES ES04743280T patent/ES2299841T3/es not_active Expired - Lifetime
- 2004-07-07 EP EP04743280A patent/EP1651227B1/de not_active Expired - Lifetime
- 2004-07-07 CA CA002531643A patent/CA2531643A1/en not_active Abandoned
- 2004-07-07 WO PCT/GB2004/002937 patent/WO2005004871A1/en not_active Ceased
- 2004-07-07 DE DE602004011781T patent/DE602004011781T2/de not_active Expired - Fee Related
- 2004-07-07 CN CNB2004800194887A patent/CN100435799C/zh not_active Expired - Fee Related
- 2004-07-07 MX MXPA06000413A patent/MXPA06000413A/es active IP Right Grant
- 2004-07-07 KR KR1020067000639A patent/KR20060034287A/ko not_active Ceased
- 2004-07-07 US US10/563,440 patent/US20060160775A1/en not_active Abandoned
2005
- 2005-12-19 IL IL172682A patent/IL172682A0/en unknown
- 2005-12-23 NO NO20056171A patent/NO20056171L/no not_active Application Discontinuation
2006
- 2006-01-09 ZA ZA200600188A patent/ZA200600188B/xx unknown

Also Published As

Publication number	Publication date
BRPI0412450A (pt)	2006-09-19
DE602004011781D1 (de)	2008-03-27
JP2007526887A (ja)	2007-09-20
AU2004255023B2 (en)	2007-09-27
HK1089384A1 (en)	2006-12-01
CA2531643A1 (en)	2005-01-20
KR20060034287A (ko)	2006-04-21
CN1819830A (zh)	2006-08-16
ATE385798T1 (de)	2008-03-15
DE602004011781T2 (de)	2009-02-19
GB0316123D0 (en)	2003-08-13
IL172682A0 (en)	2006-04-10
ES2299841T3 (es)	2008-06-01
AU2004255023A1 (en)	2005-01-20
US20060160775A1 (en)	2006-07-20
EP1651227B1 (de)	2008-02-13
WO2005004871A1 (en)	2005-01-20
ZA200600188B (en)	2007-04-25
EP1651227A1 (de)	2006-05-03
CN100435799C (zh)	2008-11-26
MXPA06000413A (es)	2006-03-17

Legal Events

Date	Code	Title	Description
2011-02-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
GB0223380D0 (en)	2002-11-13	Combination therapy
CY1111547T1 (el)	2015-08-05	Συνδυασμος zd6474 και πεμετρεξεδης
CY1111482T1 (el)	2015-08-05	Συνδυασμος azd2171 και πεμετρεξεδης
MX2007003506A (es)	2007-05-10	Terapia de combinacion de cancer que comprende azd2171 e imatinib.
MX2007003505A (es)	2007-05-10	Combinacion que comprende zd6474 e imatinib.
PL1653964T3 (pl)	2009-01-30	Skojarzone leczenie raka obejmujące AZD2171 i ZD1839
NO20056171L (no)	2006-02-07	Kombinasjonsterapi
NO20064755L (no)	2006-10-20	Kombinasjonsterapi
NO20064754L (no)	2006-10-20	Kombinasjonsterapi
WO2005092384A3 (en)	2006-11-02	Combination therapy with azd2171 and a platinum anti-tumour agent
WO2007003933A3 (en)	2007-12-27	Combination therapy of cancer with azd2171 and gemcitabine
ATE339209T1 (de)	2006-10-15	Kombinationstherapie mit gemzitabin und zd6126